Reading NHI? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NHI free→Reading NHI? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NHI free→QuarterlyIQ Insights · NHI
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition On May 4, 2026 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended March 31, 2026. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. CFO Transition On April 21, 2026, John L. Spaid notified the Board of Directors (the “Board”) of National Health Investors, Inc. (the “Company”) of his intention to retire from his position as Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of July 1, 2026. Mr. Spaid’s retirement is not the result of any dis…
to the extent such information is responsive to the disclosure requirements of
Entry into a Material Definitive Agreement. On April 21, 2026 (the “Effective Date”), National Health Investors, Inc. on behalf of itself and its affiliates identified in the Agreement (collectively, the “Company”) entered into a Purchase and Sale Agreement (the “Agreement”) with NHC/OP, L.P., a Delaware limited partnership (the “Purchaser”) and a wholly-owned subsidiary of National HealthCare Corporation (“NHC”), on behalf of itself and its affiliates identified in the Agreement, each of whi…
of this report is incorporated by reference into this
to the extent such information is responsive to the disclosure requirements of
Other Events On March 16, 2026, National Health Investors, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with each of BMO Capital Markets Corp., BofA Securities, Inc., Cantor Fitzgerald & Co., Huntington Securities, Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., PNFP Capital Markets, Inc., Regions Securities LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo Securities, LLC, as sales agents, principals and/…
Results of Operations and Financial Condition On February 26, 2026 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 17, 2026, the Board of Directors (the “Board”) of National Health Investors, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, increased the size of the Board and appointed Lilly H. Donohue to fill the vacant seat, effective immediately, with an initial term expiring at the 2026 annual m…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 15, 2025, National Health Investors, Inc. (the “Company”) entered into a Change in Control Severance Agreement (a “CIC Severance Agreement”) with each of the following named executive officers of the Company: D. Eric Mendelsohn, Kristin S. Gaines, Kevin C. Pascoe, John L. Spaid and David L. Travis (each, an “Executive”). Each of the CIC…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 5, 2025, Robert G. Adams, a member of the Board of Directors (the “Board”) of National Health Investors, Inc. (the “Company”), notified the Board that he will not be standing for reelection at the Company’s 2026 annual meeting of stockholders (the “2026 Annual Meeting”). Mr. Adams’ term will end at the Company’s 2026 annual meeting of s…
Results of Operations and Financial Condition On November 6, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended September 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Entry Into a Material Definitive Agreement. On September 26, 2025, National Health Investors, Inc. (the “Company”) completed an underwritten public offering of $350,000,000 aggregate principal amount of its 5.350% Senior Notes due 2033 (the “Notes”), which are fully and unconditionally guaranteed by the Guarantors (as defined below). The terms of the Notes are governed by a base indenture, dated as of January 26, 2021, by and between the Company, as issuer, and Regions Bank, as trustee (the “…
The Notes and the guarantees are general senior unsecured obligations of the Company and each Guarantor, respectively, and rank equally in right of payment with all of such entities’ existing and future senior unsecured, unsubordinated indebtedness. The notes and the guarantees, however, are effectively subordinated to all of the Company’s and each Guarantor’s existing and future secured indebtedness, respectively (to the extent of the value of the collateral securing such indebtedness). The…
Results of Operations and Financial Condition On August 6, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended June 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Results of Operations and Financial Condition. On May 5, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended March 31, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Departure of Directors or Certain Officers: Election of Directors: Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. (d) Election of New Director. On March 27, 2025, National Health Investors, Inc. (the “Company” or “NHI”) announced that, upon the recommendation of its Nominating and Corporate Governance Committee, it has increased the size of the Board to eight members and has appointed Robert W. Chapin, Jr. to fill the newly created seat on the Board, effective…
Results of Operations and Financial Condition. On February 25, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2024. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements for Certain Officers. On February 7, 2025, Robert T. Webb notified National Health Investors, Inc. (the “Company”) of his decision to resign from his position as a member of the Board of Directors (the “Board”) effective immediately. In connection with his retirement, Mr. Webb will no longer serve as a member of the Compensation Committee, Audit Committee, or the Nomin…
Importance-ranked changes since the prior daily snapshot.
Valuation fell by 11.8 points (from 58.1 to 46.3).
Valuation label changed from 'full' to 'expensive'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.